Abstract
Provided herein are novel heterocyclic compounds as 5-HT2C agonists, pharmaceutical compositions, use of such compounds in treating depression, drug addiction, alcoholism, post-traumatic stress disorder (PTSD) and neuropathic pain and processes for preparing such compounds.